- Home
- BLX vs BCRX Comparison
BLX vs BCRX Comparison
Compare BLX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLX | BCRX |
|---|---|---|
| Founded | 1977 | 1986 |
| Country | Panama | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1997 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BLX | BCRX |
|---|---|---|
| Price | $59.50 | $9.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $20.82 |
| AVG Volume (30 Days) | 205.5K | ★ 6.5M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $18.36 | N/A |
| Revenue Next Year | $9.95 | $12.55 |
| P/E Ratio | $8.26 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $38.41 | $6.00 |
| 52 Week High | $63.20 | $11.22 |
Technical Indicators
Market Signals| Indicator | BLX | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.86 | 47.07 |
| Support Level | $56.74 | $8.13 |
| Resistance Level | $63.20 | $9.61 |
| Average True Range (ATR) | 1.72 | 0.51 |
| MACD | -0.12 | -0.16 |
| Stochastic Oscillator | 39.81 | 18.06 |
Price Performance
Historical ComparisonAbout BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.